Intuitive Surgical: Widman sells 4,047 shares
The 4,047-share sale consisted of multiple transactions with reported prices ranging from $444.44 to $458.02 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Intuitive Surgical Inc. (ISRG) VP Corporate Controller Fredrik Widman exercised 11 non-qualified stock options on October 23, 2026, acquiring 4,047 common shares, and sold 4,047 common shares at a weighted-average price of $453.2059 per share. The sale executions ranged from $444.44 to $458.02 per share. The transactions were reported under a Rule 10b5-1 trading plan expiring September 15, 2027.
Insider Trade Summary 10b5-1
Exercise and Sale: 4,047 shares ($907K approx. pre-tax spread)
Exercise and Sale
23 txns
Insider
Widman Fredrik
Role
VP Corporate Controller
Sold
4,047 shs ($1.83M)
Approx. gross sale proceeds
$1.83M
Approx. exercise cost
$927K
Approx. pre-tax spread
$907K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) F1, F3 | 325 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F4 | 262 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F4 | 325 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F5 | 567 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F3 | 263 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F6 | 307 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F4 | 567 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F5 | 406 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F5 | 312 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F7 | 307 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F4 | 406 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 307 | $304.67 | $94K |
| Exercise | Common Stock F1 | 307 | $229.39 | $70K |
| Exercise | Common Stock F1 | 312 | $290.33 | $91K |
| Exercise | Common Stock F1 | 406 | $347.4167 | $141K |
| Exercise | Common Stock F1 | 406 | $245.60 | $100K |
| Exercise | Common Stock F1 | 567 | $242.3367 | $137K |
| Exercise | Common Stock F1 | 567 | $177.9867 | $101K |
| Exercise | Common Stock F1 | 262 | $166.6233 | $44K |
| Exercise | Common Stock F1 | 263 | $182.8333 | $48K |
| Exercise | Common Stock F1 | 325 | $174.2567 | $57K |
| Exercise | Common Stock F1 | 325 | $139.52 | $45K |
| Sale | Common Stock F1, F2 | 4,047 | $453.2059 | $1.83M |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 8,522 contracts (Direct);
Common Stock — 1,026 shares (Direct)
Footnotes (7)
- F1. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 15, 2027.
- F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $444.44 to $458.02 as follows: 40 shares sold at $444.44; 120 shares sold at $445.55 to $446.44; 80 shares sold at $446.76; 120 shares sold at $448.14 to $448.37; 200 shares sold at $449.30 to $450.22; 80 shares sold at $450.34 to $451.17; 1,447 shares sold at $451.98 to $452.97; 480 shares sold at $453.01 to $453.84; 360 shares sold at $454.02 to $455.00; 400 shares sold at $455.27 to $455.78; 480 shares sold at $456.33 to $457.19; and 240 shares sold at $457.42 to $458.02. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F3. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
- F4. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
- F5. Non-statutory stock option granted pursuant to the 2010 Incentive Awards Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
- F6. 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
- F7. 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
Key Figures
Common shares acquired through option exercises: 4,047 shares
Common shares sold: 4,047 shares
Weighted-average sale price: $453.2059 per share
+2 more
5 metrics
Common shares acquired through option exercises
4,047 shares
11 option exercises on October 23, 2026
Common shares sold
4,047 shares
October 23, 2026
Weighted-average sale price
$453.2059 per share
Sale on October 23, 2026
Sale execution price range
$444.44 to $458.02 per share
Multiple sale transactions
Rule 10b5-1 trading plan expiration
September 15, 2027
Plan covering the reported transactions
Key Terms
Non-Qualified Stock Option, Rule 10b5-1, weighted average sale price, non-statutory stock option
4 terms
Non-Qualified Stock Option technical
"Non-Qualified Stock Option (right to buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Rule 10b5-1 regulatory
"Trading Plan that complies with SEC Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
weighted average sale price financial
"The price reported in Column 4 is a weighted average sale price"
non-statutory stock option technical
"Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan"
A non-statutory stock option is a company-granted right that lets a person buy shares later at a set price but does not receive special tax-favored treatment under tax law. It matters to investors because when the option is used the holder usually pays ordinary income tax on the gain and the company records compensation cost and issues new shares, which can reduce existing owners’ percentage ownership—think of it like a coupon to buy stock that creates a taxable event and some dilution.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.
